Valiant Organics Ltd (VALIANTORG) is currently trading at 366.75 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Valiant Organics Limited manufactures benzene‑based specialty chemical intermediates used by agrochemicals, pharmaceuticals, dyes, pigments and veterinary sectors, operating six integrated manufacturing plants across five locations in western India and reporting approximately 80,000 MTPA installed capacity, 900+ employees, and a market capitalization near INR 567 crore as of March 31, 2026. After revenue volatility from FY23 to FY25, Valiant reported consolidated revenue of INR 739 crore in FY26 with EBITDA recovering to INR 101 crore and a 13.64% margin, PAT returning to positive INR 34 crore, net debt-to-equity steady at 0.33 and ROCE improving to 8.02%, signaling margin recovery but modest profitability. Valiant derives nearly half of revenue from hydrogenation chemistries (48%) and almost 45% of revenues serve the dyes and pigments end market, positioning the company as a leading domestic substitute to imports for specific intermediates such as chlorophenols, PNA and anisidines, reflecting focused product expertise but sector concentration risk. Integrated multi‑use plants, backward integration, five Zero Liquid Discharge facilities and strategic plant siting near western ports give Valiant Organics logistical advantages, improved raw‑material access and environmental compliance, supporting export orientation and customer service while reducing freight and regulatory friction for international shipments.

Over the past 52 weeks, Valiant Organics Ltd has traded between a low of ₹195.20 and a high of ₹507.90. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Valiant Organics Ltd has a market capitalization of approximately 1,214.32. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Valiant Organics Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 24.04 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 1,214.32 Cr, Valiant Organics Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Valiant Organics Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Valiant Organics Ltd is 24.04. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Valiant Organics Limited is scheduled to hold its board meeting on November 5, 2026. The board will consider unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026.

The provided text reports consolidated revenue from operations of ₹231.54 crore and consolidated net profit of ₹29.26 crore for the quarter ended June 30, 2026.

The Board approved the unaudited standalone and consolidated results in its meeting held on February 13, 2026.